Lungwort for Coughs and Chest Complaints

This is the page where a herb usually earns its keep. For lungwort it is mostly a page about a hole in the literature, and the hole is the finding — so it is written up as one rather than glossed over.

Everything below is about Pulmonaria officinalis, the borage-family plant, unless a sentence names Lobaria pulmonaria. The identity page explains why that distinction is not optional. What you will find here: what the tradition actually recommended and for what; the demulcent rationale stated as fairly as it can honestly be stated, and then the two places where it breaks; what the laboratory work does and does not establish; a numbered list of the human evidence that does not exist; the specific instruments a real lungwort cough trial would use, all of which exist and none of which has been pointed at this plant; and the cough remedies that do have trials, so that “nobody tests traditional herbs” cannot be used as a defence.

Table of Contents

  1. What the Tradition Actually Recommended
  2. The Demulcent Rationale, Stated Fairly
  3. A Swallowed Demulcent Does Not Reach the Bronchi
  4. Mucilage and the Tincture Problem
  5. Soothing and Drying at the Same Time
  6. What Actually Extracts Into a Cup
  7. The Laboratory Findings and Their Limits
  8. The Human Evidence: What Is Missing
  9. How a Lungwort Cough Trial Would Be Run
  10. Why the Trial Is Genuinely Hard to Design
  11. Cough Remedies That Do Have Trials
  12. The Lichen's Respiratory Reputation Is Thinner Still
  13. What the Regulators Concluded
  14. Key Research Papers
  15. Connections

What the Tradition Actually Recommended

European folk and apothecary use of lungwort herb is reasonably consistent across sources. It was a demulcent and mild expectorant for the airways, given as a warm infusion of the dried leaf or flowering top, as a honey or sugar syrup, and later as an alcoholic tincture. The named indications were dry irritating cough, hoarseness and laryngitis, bronchitis and chest congestion, and sore throat. It very rarely stood alone: it appears as one component of respiratory tea and syrup blends alongside mullein, marshmallow root, thyme, licorice, ribwort plantain and coltsfoot.

A second, quieter tradition used it as an astringent: for urinary-tract irritation, for looseness of the bowels, and externally on cuts, grazes and haemorrhoids. The young leaves were also eaten as a cooked spring green in parts of Europe. Both of those matter later — the astringent claim because it contradicts the demulcent one, and the eaten-as-a-vegetable habit because it is a repeated-exposure route rather than a five-day course.

There is one historical indication that deserves to be said out loud, because it is the sharpest available illustration of what a signature-derived lung remedy was actually used for. Lungwort was among the herbs given for consumption — pulmonary tuberculosis — and for other wasting chest diseases. It did nothing for tuberculosis. Nothing did, until antibiotics. A tradition can be centuries old, sincerely maintained, internally coherent and aimed at a disease it cannot touch. That is the correct frame for reading any claim that lungwort is “for the lungs.”

The Demulcent Rationale, Stated Fairly

The demulcent story is the strongest thing lungwort has, and it deserves to be put at its best before it is taken apart.

A demulcent is a preparation containing mucilage — long-chain polysaccharides that dissolve into a viscous, slippery colloid. Poured over an inflamed pharynx, that colloid forms a physical film. The proposed benefits are mechanical rather than pharmacological: it reduces the friction and dryness that provoke the tickle, and it may physically shield irritated mucosal nerve endings from the airflow and from inflammatory mediators. Nothing about that requires absorption, a receptor or a metabolic pathway. It is closer to a lubricant than a drug, which is exactly why it is plausible.

Lungwort leaf does contain mucilage; that is not in dispute, and it is consistent with the plant's slightly slimy quality when infused. So the mechanism is available in principle, and a warm lungwort infusion sipped for a raw throat is doing something real, in the same modest sense that a warm honey drink is.

Two honest qualifications belong right here, before the objections. First, we cannot tell you how much mucilage is in it. Marshmallow root has been characterised to the point where its mucilage content is a specified quality parameter; lungwort has not. Any milligram figure we printed would be invented, so we are not printing one. Second, mucilage is common. It is not a distinguishing feature of lungwort but a property shared with marshmallow, plantain, mullein, slippery elm and, for that matter, honey and oatmeal. If the mucilage is the mechanism, then lungwort is one of the least-characterised members of a large and interchangeable class.

A Swallowed Demulcent Does Not Reach the Bronchi

This is the single most important correction on the page, and it applies to every mucilage herb on this site — the plantain page makes the same argument.

When you swallow a lungwort infusion, it passes over the tongue and pharynx and down the oesophagus. It does not enter the trachea. The larynx exists precisely to prevent that, and if a mouthful of tea did reach your bronchi you would be coughing for a quite different reason. So there is no route by which a swallowed demulcent can coat the lower airway. Any claim that lungwort “soothes and coats the bronchial tubes” is anatomically impossible as stated.

Where a demulcent can act, then, is the throat — the area it makes contact with. There is one further possibility worth taking seriously: a reflex effect. Sensory afferents in the pharynx and upper oesophagus feed into the same vagal circuitry that governs the cough reflex, and stimulation there — by warmth, by sweetness, by viscosity — may raise the cough threshold centrally. Ronald Eccles has argued this case in the cough literature for sweet syrups specifically. If lungwort helps a chest cough at all, this reflex route is the only plausible mechanism, and note what it implies: the effect would belong to the warm sweet viscous drink rather than to Pulmonaria.

The consequence is a distinction the traditional literature blurs and this site insists on:

And here is the specific problem for lungwort. The classic reflex-expectorant mechanism in herbal medicine is attributed to saponins — the irritant surfactant glycosides that underpin the expectorant claims for ivy leaf, licorice, primrose root and soapwort. Pulmonaria is not a notable saponin plant; its characterised chemistry is phenolic acids, mucilage, tannins, silicic acid and allantoin. So the plant lacks the compound class that the traditional expectorant story actually depends on. The expectorant label appears to have been inherited from the name and the company it kept in blends, not from its chemistry.

Mucilage and the Tincture Problem

Lungwort is widely sold as an alcoholic tincture. If the demulcent mechanism is the reason to take it, the tincture is the wrong product.

Alcohol precipitates mucilage. High-percentage ethanol drops polysaccharides out of solution rather than extracting them — it is one of the standard bench methods for isolating them. A tincture therefore delivers the alcohol-soluble fraction: rosmarinic acid and the other phenolics, some tannin, whatever alkaloid is present. It does not deliver a colloid capable of coating a throat.

That makes water infusion and alcoholic tincture two different interventions from the same plant, and it means a claim justified by mucilage cannot be transferred to a tincture. It also runs the other way: the in-vitro studies discussed below mostly used alcoholic or hydro-alcoholic extracts, so their findings do not automatically transfer to a cup of tea either. This is the same solvent-substitution trap the site flags on boneset and plantain, and it is easy to miss because the species, the plant part and the word “extract” all match.

Soothing and Drying at the Same Time

Traditional sources credit lungwort with being both demulcent and astringent, often in the same paragraph. Those are opposing actions and the tension is worth reporting rather than resolving in the plant's favour.

A demulcent leaves a hydrated, slippery polysaccharide film. An astringent works by the opposite chemistry: tannins cross-link and precipitate surface proteins, producing the puckered, dried sensation of strong tea. Tannins also precipitate polysaccharides and mucoproteins — that is, an astringent fraction actively works against a mucilage fraction in the same cup.

The traditional resolution was to call the plant a tonic, a word vague enough to absorb the contradiction. This site has flagged the same manoeuvre for raspberry leaf, where two 1941 papers disagreed about whether the extract relaxed or inhibited uterine muscle and “tonic” survived precisely because it accommodated both.

Candidate reconciliations, none of them tested:

  1. Both fractions are present at low concentration and neither effect dominates, so the perceived action is mostly the warmth and the sweetener.
  2. Preparation decides. A short or cool infusion favours mucilage; long steeping or decoction pulls more tannin. If so, “lungwort tea” is not one intervention.
  3. Site decides. Astringency is felt on the tongue and pharynx; a mucilage film may persist further down. Both sensations could be real in different places.

We do not know which, if any, is correct, and saying so is more useful than picking the flattering half.

What Actually Extracts Into a Cup

Lungwort passes one test that trips up many herbs on this site. Its headline compound, rosmarinic acid, is water-soluble, so an infusion genuinely does extract it. Contrast the common error of citing a triterpene result — ursolic or oleanolic acid, poorly water-soluble — as if it applied to a tea; that trap has been flagged here on vervain and self-heal, and it does not apply to lungwort's main phenolics. Credit where due.

Three limits follow immediately, though.

Rosmarinic acid is not lungwort's property. It is abundant in sage, rosemary, lemon balm, spearmint, perilla and self-heal. Any finding about the molecule is a finding about the molecule. Attributing it to lungwort specifically is compound substitution, and the site's rosmarinic acid page works through what is and is not known about it in more detail than we will repeat here.

Its oral bioavailability is poor. Rosmarinic acid is incompletely absorbed, extensively conjugated to glucuronides and sulfates, and partly degraded by gut bacteria to smaller phenolic acids. Human plasma concentrations after realistic dietary or beverage doses land far below the concentrations used in cell-free and cell-culture assays. That gap is the reason an in-vitro enzyme-inhibition result is a starting point rather than a conclusion.

Nobody has measured the cup. There is no published figure for how much rosmarinic acid, mucilage or anything else a standard lungwort infusion delivers, nor for how much varies with harvest season — even though the 2018 profiling work found the metabolite profile differs between spring and autumn material. So the dose is unknown at both ends: unknown in the cup and unknown in the blood.

The Laboratory Findings and Their Limits

What exists for Pulmonaria is a small, decent, recent body of in-vitro chemistry. Taken on its own terms it is respectable work; the problem is only what it is asked to support.

Sum: lungwort extract is chemically active in vitro, in the way that most phenolic-rich plant extracts are. There is no in-vivo respiratory model, no animal cough or bronchitis study, and no human data of any kind.

The Human Evidence: What Is Missing

Rather than leave this as an impression, here is the gap as an explicit list of findings. Each item is absent evidence, not negative evidence — nothing below was tested and failed; it was never tested. That distinction matters in both directions.

  1. No randomised controlled trial of Pulmonaria officinalis for cough, acute bronchitis, sore throat, hoarseness or any other respiratory outcome. Not a small one, not an unblinded one, not a poor one.
  2. No dose-finding study. There is no established human dose. The teaspoon-per-cup figures in secondary sources are custom, not pharmacology.
  3. No human pharmacokinetics. No measurement of any lungwort constituent in blood or urine after drinking the tea; no data on how long a mucilage film persists on the pharynx.
  4. No repeat-dose toxicology. No published sub-chronic animal study of the leaf, and therefore no no-observed-adverse-effect level to anchor a duration limit.
  5. No content survey of commercial products — not for mucilage, not for phenolics, and most importantly not for pyrrolizidine alkaloids, which the safety page takes up.
  6. No interaction study of any kind. If a source tells you lungwort has “no known drug interactions,” read that as no interaction study exists. It is absent data, not reassurance.
  7. No paediatric, pregnancy or lactation data. For a Boraginaceae herb, that is the gap that matters most.
  8. No active-comparator study. Lungwort has never been compared with honey, ivy leaf, marshmallow or anything else.
  9. No mechanistic test in a human airway. No cough-challenge study, no cough-frequency measurement, no mucociliary clearance measurement.
  10. No identity survey. Nobody has published an analysis of what is actually in bags sold as “lungwort,” even though two organisms from different kingdoms are sold under that name.

Ten gaps, and the first one is the only one that would need filling for the herb to have a respiratory claim at all.

How a Lungwort Cough Trial Would Be Run

The strongest reply to “you cannot run trials on a gentle traditional herb” is to describe the trial. Cough is one of the better-instrumented symptoms in respiratory medicine, and every tool below is validated and in routine use.

  1. Objective cough frequency. Ambulatory acoustic cough monitors — the Leicester Cough Monitor and VitaloJAK among them — record and count coughs over 24 hours, giving coughs per hour as a hard, blinded, machine-scored endpoint.
  2. Cough reflex sensitivity. Inhalation challenge with capsaicin or citric acid, reporting the concentration causing two or five coughs. This measures the reflex threshold directly and would test the reflex hypothesis described above.
  3. Validated patient-reported outcomes. The Leicester Cough Questionnaire for cough-specific health status; a cough visual analogue scale; a cough severity diary. For acute bronchitis specifically, the Bronchitis Severity Score is the endpoint used in the ivy-leaf and Pelargonium trials, which means lungwort could be measured on the same scale as its better-studied competitors.
  4. Throat-specific outcomes, since the throat is where a demulcent can actually act: sore-throat pain scales and time to first relief, as used in lozenge trials.
  5. Clearance measures, if an expectorant claim is being tested: saccharin transit time or radiolabelled aerosol clearance for mucociliary function, and sputum weight or rheology.
  6. Course and rescue use. Time to resolution, days of impaired sleep, rescue-medication consumption, days off work.
  7. Safety endpoints chosen for this plant. Baseline and end-of-study liver enzymes, given that this is a Boraginaceae herb. That is the specific, appropriate safety measure, and it has never been collected for lungwort in any human.

The European Respiratory Society has published guidance on cough assessment, and the instruments above are the standard toolkit. None of them has been applied to either lungwort. The tools exist and were simply never pointed at this plant — which is a different and more damning statement than “the evidence is limited.”

Why the Trial Is Genuinely Hard to Design

Absence is a finding, but honesty requires distinguishing “nobody bothered” from “this is genuinely difficult,” and for demulcents part of it is genuinely difficult.

The central problem is that a sweet viscous syrup is not an inert placebo. Sweet taste appears to raise the cough threshold on its own, and viscosity may do the same. So a trial comparing lungwort syrup against a sweet syrup base is comparing an active treatment against another active treatment, and will tend to find no difference even if the herb does something. Comparing it against water or a bitter vehicle breaks the blind instantly, because the taste is distinctive. The available workarounds — matched-viscosity vehicles, dose-ranging designs, cross-over designs with objective cough counts — are all imperfect.

Two further difficulties: acute cough resolves on its own within one to three weeks, so a trial needs either a large sample or a chronic-cough population that is not the traditional target; and cough trials record large placebo responses, which raises the sample size needed to detect a modest real effect.

None of this excuses the total absence, and here is why. Honey, ivy leaf, Pelargonium, thyme-primrose and marshmallow root all face exactly the same design problems, and all of them have been trialled anyway. The difficulty is real; it is not the reason lungwort has no data. The reason is that nobody with the means to run a trial has been interested in a herb with no commercial extract behind it.

Cough Remedies That Do Have Trials

If you have a cough and you want the best-supported gentle option, the honest answer is that lungwort is not on the list. These are, with the caveats attached rather than hidden:

Note what this list is not. It is not a claim that these are proven cures; several rest on modest, industry-funded evidence, and acute cough gets better regardless. It is a demonstration that gentle traditional respiratory remedies can be and have been trialled — which removes the last excuse for lungwort's empty record. The site's coltsfoot alternatives page covers the same ground for a herb with a much more serious safety problem.

The Lichen's Respiratory Reputation Is Thinner Still

Lobaria pulmonaria carries the same traditional indication for the same reason — it looked like a lung — and it has even less behind it. Its recorded uses run to coughs and chest complaints in European folk medicine and, in the ethnolichenological literature, to non-medical uses such as dyeing and, reportedly, as a bittering agent in beer in parts of northern Europe and Siberia. We flag the beer use as reported rather than established.

What its modern literature actually consists of is chemistry, ecology, air-quality biomonitoring and conservation genetics. There is no controlled human trial of tree lungwort for any respiratory condition, and no animal model either. Its constituents — the stictic-acid group of depsidones and related lichen substances — have no demulcent action to appeal to; a lichen contains no mucilage of the marshmallow kind, so even the plausible mechanism available to Pulmonaria is unavailable here.

And to be explicit, because this is exactly the mistake the shared name invites: nothing in the Pulmonaria literature above is evidence about the lichen, and nothing in the lichen literature is evidence about the plant. They are separate organisms with separate, non-overlapping chemistries and separate, equally empty clinical records.

What the Regulators Concluded

Regulatory positions on herbs need reading rather than quoting, because the instruments measure different things. Two matter here.

A traditional-use registration in the European system requires documented long-standing use plus plausible pharmacology, and explicitly does not require efficacy trials. That is why a herb can hold such a registration and still have no trial data — and it is why the site's coltsfoot and horehound pages can report an official registration and an absence of evidence without contradiction. For Pulmonaria officinalis we could find no European Medicines Agency herbal monograph at all, which means lungwort does not clear even that deliberately low bar. Readers can check the current listing on the European Medicines Agency site.

The German Commission E monographs are the other relevant instrument, and they are judgements resting on tradition plus plausibility rather than on trial results. Lungwort herb appears among the unapproved monographs — a negative assessment issued on the ground that efficacy was not documented. We are relying on secondary summaries of the published monograph collection rather than the German original, so treat our wording as a summary to verify rather than a quotation.

One subtlety is worth spelling out, because it cuts against a lazy reading. A Commission E “negative” verdict here does not mean lungwort was tested and failed. It means the documentation was judged insufficient to support the claim. That is an absent-evidence verdict wearing the word “negative,” and conflating it with a failed trial would be unfair to the plant in the same way that calling untested herbs “disproven” is unfair. The accurate statement is narrower and still unflattering: lungwort has never been shown to work, has never been shown not to work, and has not accumulated enough documentation for any regulator to endorse the tradition.

Back to Table of Contents

Key Research Papers

Each entry is labelled with the organism, preparation or subject actually studied. Links are PubMed topic and title searches rather than fixed record numbers.

  1. [P. officinalis, chemistry] Krzyżanowska-Kowalczyk and colleagues, “Novel Phenolic Constituents of Pulmonaria officinalis L. LC-MS/MS Comparison of Spring and Autumn Metabolite Profiles,” Molecules, 2018 — PubMed. Establishes rosmarinic acid and related caffeic-acid oligomers as the dominant phenolics, and that the profile shifts with season.
  2. [P. obscura and P. officinalis, in vitro] Krzyżanowska-Kowalczyk and colleagues, “Pulmonaria obscura and Pulmonaria officinalis Extracts as Mitigators of Peroxynitrite-Induced Oxidative Stress and Cyclooxygenase-2 Inhibitors,” Molecules, 2021 — PubMed. Isolated human plasma plus docking; two species studied side by side.
  3. [P. officinalis, in vitro enzyme screen] Neagu and colleagues, “Antioxidant activity, acetylcholinesterase and tyrosinase inhibitory potential of Pulmonaria officinalis and Centarium umbellatum extracts,” Saudi Journal of Biological Sciences, 2018 — PubMed. Screening assays; the tyrosinase result is a depigmenting property, not a respiratory one.
  4. [P. officinalis, ethanolic extract] A 2025 paper in Pharmaceutics assessing antioxidant activity together with dose-dependent genotoxicity and antigenotoxicity of a Pulmonaria officinalis ethanolic extract — PubMed. Relevant to concentrated extracts rather than to tea.
  5. [Rosmarinic acid, compound level — not lungwort] Amoah and colleagues, “Rosmarinic Acid — Pharmaceutical and Clinical Aspects,” Planta Medica, 2016 — PubMed.
  6. [Rosmarinic acid, human pharmacokinetics] Absorption, conjugation and microbial degradation of rosmarinic acid — PubMed topic search. The reason in-vitro concentrations do not describe a cup of tea.
  7. [Cough, mechanism and methodology] Eccles, “The powerful placebo in cough studies?”, Pulmonary Pharmacology & Therapeutics, 2002 — PubMed.
  8. [Cough, mechanism and methodology] Eccles, “Mechanisms of the placebo effect of sweet cough syrups,” Respiratory Physiology & Neurobiology, 2006 — PubMed. The reason a demulcent trial is genuinely hard to design.
  9. [Honey, children, acute cough] Cochrane review of honey for acute cough in children — PubMed. A trialled comparator, and the vehicle traditional lungwort syrup used.
  10. [Pelargonium sidoides] Cochrane review of Pelargonium sidoides extract for acute respiratory tract infections — PubMed.
  11. [Hedera helix, ivy leaf] Clinical literature on standardised ivy-leaf dry extract in acute bronchitis — PubMed topic search. Saponin-based reflex expectorant — the mechanism lungwort's chemistry cannot supply.
  12. [Thyme and primrose] Kemmerich and colleagues on a fixed combination of thyme herb and primrose root in adults with acute bronchitis and productive cough, Arzneimittelforschung, 2007 — PubMed.
  13. [Cough, measurement] Birring and colleagues on the Leicester Cough Questionnaire (Thorax, 2003) and the Leicester Cough Monitor (European Respiratory Journal, 2008) — PubMed. Two of the validated instruments never applied to lungwort.
  14. [Cough, guidance] European Respiratory Society guidelines on the assessment of cough — PubMed. Includes capsaicin and citric-acid challenge methodology.
  15. [Either lungwort, clinical] A direct search for human trials — Pulmonaria and Lobaria — returns nothing usable for either organism. The empty result is the finding.

Back to Table of Contents

Connections

Back to Table of Contents